In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement ...
5 hours ago
0
0
Problematic use of social media—characterized by loss of control and compulsive engagement—may significantly increase depressive symptoms in adolescents under the age of 16, according to a new study led by researchers ...
11 hours ago
0
0
How can the onset of psychotic symptoms characteristic of schizophrenia be explained? Despite their major and often irreversible impact on intellectual abilities and autonomy, the biological mechanisms that precede their ...
5 hours ago
0
1
For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research from University of Florida scientists suggests that what happens inside the muscle, not just inside ...
8 hours ago
0
0
A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral suppression and demonstrated ...
7 hours ago
0
0
The first major update to resistance-training guidelines in 17 years delivers one clear message: any amount of resistance training improves strength, muscle size, power and physical function.
9 hours ago
0
0
A new study has mapped by age young children's ability to understand and practice deception for the first time—and results indicate many can sense it even before turning 1 year old. The research, led by the University of ...
7 hours ago
0
0
A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to researchers at UNIST. Led by Professor Joo Hun Kang in the Department of Biomedical Engineering at UNIST, ...
7 hours ago
0
0
Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That superhero is a gene called TP53, and for decades scientists have known it as the "guardian of the ...
8 hours ago
0
0
In a clinical trial, a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of abstinence from illicit opioids ...
4 hours ago
0
0
